Effects of Anti-IL-13 (Novartis QAX576) on Inflammatory Responses Following Nasal Allergen Challenge (NAC).

HH Kariyawasam; Geoffrey C. Nicholson; AJ Tan; N Syngal; Damian Quinn; Christina Boulton; Christoph Walker; David M. Rodman; John Westwick; Onn Min Kon; Peter J Barnes; Jens M. Hohlfeld; Philipp Badorrek; N. Krug; TT Hansel

doi:10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3642

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2011

The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge

Grant C. Nicholson, Harsha H. Kariyawasam, Andrew J. Tan, Jens M. Hohlfeld, Deborah A. Quinn, Christoph Walker, David M. Rodman, John Westwick, Stipo Jurčević, Onn Min Kon, Peter J Barnes, Norbert Krug, Trevor T. Hansel

Article2005

Topical corticosteroid inhibits interleukin‐4, ‐5 and ‐13 in nasal secretions following allergen challenge

Edward M. Erin, Angela Zacharasiewicz, Grant C. Nicholson, Andrew J. Tan, L. A. Higgins, Timothy J. Williams, R.D. Murdoch, Stephen R. Durham, Peter J Barnes, Trevor T. Hansel

Article2005

Single dose topical corticosteroid inhibits IL‐5 and IL‐13 in nasal lavage following grass pollen challenge

L. A. Higgins, Timothy J. Williams, Malcolm Boyce, Peter de Boer, Stephen R. Durham, Peter J Barnes, Trevor T. Hansel, Edward M. Erin, Brian Leaker, Angela Zacharasiewicz

Article2015

Using magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitis

Brian Leaker, Glenis Scadding, Clare Jones, Peter J Barnes

Article1996

Priming of circulating human eosinophils following late response to allergen challenge

DJ Evans, Mark A. Lindsay, BJ O'Connor, Peter J Barnes